
    
      Dose ranging study with three consecutive dose escalation cohorts. The study objectives are
      to demonstrate that FG-4592 is effective in maintaining hemoglobin (Hb) levels when
      converting from epoetin alfa and to establish optimum starting doses and dose adjustment
      regimens for Hb maintenance.
    
  